Facebook tracking pixel
S10.AI
ICD-10-CM · I25.119GeneralSystemic

Coronary Artery Disease with Angina

Understand Coronary Artery Disease with Angina (CAD with Angina) diagnosis, clinical documentation, and medical coding. Find information on Ischemic Heart Disease with Angina, including symptoms, treatment, and healthcare resources. Learn about accurate coding for CAD with Angina and best practices for clinical documentation to support optimal patient care.

Also known as
CAD with AnginaIschemic Heart Disease with Angina
Definition

Narrowed heart arteries reduce blood flow, causing chest pain (angina).

Clinical signs

Chest pain or pressure, shortness of breath, nausea, fatigue.

Common settings

Cardiology clinic, emergency room, cardiac catheterization lab.

Related Codes

ICD-10 Code Families

Complete code families applicable to I25.119

I20-I25
Ischemic heart diseases
I24
Other acute myocardial infarction
I25
Chronic ischemic heart disease
Code Comparison

When to use each related code

DescriptionWhen to use
Chest pain due to reduced blood flow to the heart.Use when angina (chest pain) is present due to narrowed coronary arteries. Include details about angina type and severity.
Reduced blood flow to heart, no chest pain.Use for coronary artery disease (CAD) diagnosed by imaging or testing, but without angina symptoms. Specify diagnostic method.
Chest pain, but cause other than CAD.Use for chest pain when investigations rule out CAD. Specify the cause of chest pain, e.g., musculoskeletal, gastrointestinal.
Documentation

Best-practice checklist

  • Document angina symptoms (frequency, duration, character, etc.)
  • CAD diagnosis supported by objective findings (ECG, stress test, angiogram)
  • Severity of angina (CCS class or NYHA class) documented
  • Impact of angina on daily activities clearly described
  • Medications and treatments for angina documented
Coding & Audit Risks

Common pitfalls to avoid

Angina Documentation

Insufficient documentation specifying angina type (stable, unstable, Prinzmetal's) may lead to inaccurate coding.

CAD Severity Coding

Lack of documentation clarifying CAD severity (e.g., single vessel vs. multi-vessel) can impact code selection and reimbursement.

Comorbidity Documentation

Incomplete documentation of coexisting conditions like hypertension or diabetes may affect risk adjustment and payment.

Mitigation

Best-practice tips

  • 01Document angina type, frequency, and duration for accurate ICD-10 coding (I20.x).
  • 02Correlate ECG, stress test, and angiography findings with angina symptoms for CDI.
  • 03Specify stable/unstable angina status and meds for HCC risk adjustment coding.
  • 04Query physician for clarity if angina documentation is vague or conflicting.
  • 05Regularly audit charts for complete angina documentation per AHA guidelines.
Clinical Decision Support

Step-by-step checklist

  1. 1

    1. Document angina symptoms (type, frequency, duration).

  2. 2

    2. Review EKG for ischemic changes (ST depression, T-wave inversion).

  3. 3

    3. Assess cardiac biomarkers (troponin, CK-MB).

  4. 4

    4. Consider coronary angiography if high suspicion of CAD.

Documentation Template

Ready-to-paste narrative

Patient presents with symptoms suggestive of Coronary Artery Disease with Angina.  The patient reports experiencing stable angina, characterized by chest pain or discomfort, pressure, tightness, or squeezing sensation in the chest, often radiating to the left arm, jaw, neck, or back.  Onset of angina is typically exertional, brought on by physical activity or emotional stress, and relieved by rest or nitroglycerin.  Risk factors for coronary artery disease, such as hypertension, hyperlipidemia, diabetes, family history of CAD, smoking history, and obesity, were assessed.  Physical examination revealed normal heart sounds and no murmurs, gallops, or rubs.  Electrocardiogram (ECG) showed no ST-segment elevations or depressions.  Initial cardiac biomarkers, including troponin, were within normal limits, ruling out acute myocardial infarction.  A diagnosis of stable angina pectoris secondary to coronary artery disease is suspected.  The patient was prescribed sublingual nitroglycerin for acute anginal episodes and a daily regimen of aspirin, a statin for cholesterol management, and an ACE inhibitor for blood pressure control.  Further evaluation with a coronary angiogram is recommended to assess the extent of coronary artery stenosis and determine the need for revascularization procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG).  Patient education regarding lifestyle modifications, including smoking cessation, dietary changes, and regular exercise, was provided.  Follow-up appointment scheduled in two weeks to review symptom control and discuss angiogram results.
FAQs

Common questions and answers

What are the most effective diagnostic strategies for stable Coronary Artery Disease with Angina, factoring in both pretest probability and cost-effectiveness for outpatient settings?+

Diagnosing stable Coronary Artery Disease with Angina in outpatient settings requires a balanced approach considering both pretest probability and cost-effectiveness. For patients with low pretest probability, initial testing with a resting ECG and exercise treadmill test is often appropriate. If the exercise test is positive or inconclusive, or if the patient cannot exercise, consider stress echocardiography or myocardial perfusion imaging. For patients with intermediate or high pretest probability, or those with concerning symptoms despite normal initial testing, coronary computed tomography angiography (CCTA) can provide valuable anatomical information about the coronary arteries. In some cases, invasive coronary angiography may be warranted, particularly if non-invasive testing suggests significant CAD or if the patient's symptoms remain uncontrolled. Choosing the right diagnostic strategy involves careful consideration of the individual patient's risk factors, clinical presentation, and preferences, along with resource availability and cost. Explore how shared decision-making can enhance patient satisfaction and improve adherence to treatment plans.

How can I differentiate stable Angina from microvascular angina and other non-obstructive Coronary Artery Disease presentations in women, considering the higher prevalence of these conditions in this patient population?+

Differentiating stable angina from microvascular angina and other non-obstructive Coronary Artery Disease (CAD) presentations in women can be challenging due to overlapping symptoms and the higher prevalence of non-obstructive CAD in this population. A thorough clinical history, including detailed symptom characterization and assessment of risk factors, is essential. While traditional exercise testing may reveal ischemia, it may not pinpoint the underlying cause. Consider incorporating imaging modalities such as cardiac PET or coronary reactivity testing to assess microvascular function. Furthermore, exploring alternative diagnoses, such as vasospastic angina, through provocative testing can be helpful. A multidisciplinary approach, potentially involving a cardiologist specializing in women's heart health, is often beneficial. Consider implementing a standardized diagnostic pathway for women presenting with chest pain to ensure appropriate evaluation and management of both obstructive and non-obstructive CAD. Learn more about the latest research on sex-specific differences in CAD presentation and diagnosis.

What are the current best practice guidelines for medical management of Coronary Artery Disease with stable Angina, focusing on optimizing antianginal therapy and secondary prevention strategies to reduce cardiovascular risk?+

Current best practice guidelines for managing Coronary Artery Disease with stable angina emphasize a comprehensive approach encompassing both symptom relief and secondary prevention. Optimizing antianginal therapy typically involves first-line treatment with beta-blockers, calcium channel blockers, and/or nitrates, titrated to achieve adequate symptom control while minimizing side effects. Secondary prevention strategies are crucial to reduce long-term cardiovascular risk and should include lifestyle modifications such as smoking cessation, regular exercise, and a heart-healthy diet. Pharmacological therapies for secondary prevention encompass antiplatelet agents, statins, and ACE inhibitors or ARBs, tailored to individual patient risk factors. Patient education and shared decision-making are paramount to ensure adherence to treatment plans and optimize outcomes. Consider implementing a structured program for cardiac rehabilitation to promote lifestyle changes and support long-term adherence to medical therapy.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.